Prosecution Insights
Last updated: August 15, 2026

Taipei Medical University

8 pending office actions • 7 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days

Portfolio Summary

8
Total Pending OAs
4
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
1
Due this week
1
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Due ≤ 7 days (1)Due ≤ 30 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (38%)
5
Medium (62%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (12%)
§101 + other1 (12%)
§103 only5 (62%)
Multi-statute (no §101)1 (12%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
38% of docket
0
Information Tech
0% of docket
2
Communications
25% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
25% of docket
1
Business / Other
12% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MOLOYE, TITILAYO 1 63.1% +47.1%
SCHACHERMEYER, SAMANTHA LYNN 1 36.1% +70.8%
SAFAIPOUR, BOBBAK 1 86.0% +10.8%
SHIAO, REI TSANG 1 79.8% -33.7%
GEBREMICHAEL, BRUK A 1 22.2% +23.7%
NEWTON, CHAD A 1 38.0% +25.0%
YANG, WEI WEN 1 81.9% +11.0%
HERBERT, MADISON TAYLOR 1 55.0% +56.3%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17978226 METHODS AND DEVICES OF PROCESSING LOW-DOSE COMPUTED TOMOGRAPHY IMAGES YANG, WEI WEN 14d
18398320 EYE IMAGE CAPTURING AND PROCESSING DEVICE SAFAIPOUR, BOBBAK

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18326004 METHOD AND APPARATUS FOR PREDICTING PERSISTENT POSTCONCUSSIVE NEUROPSYCHIATRIC SYMPTOMS USING THALAMOCORTICAL COHERENCE NEWTON, CHAD A 75d
18746300 Pharmaceutical Composition and Method for Treating Neurodegenerative Disorders Utilising the Pharmaceutical Composition MOLOYE, TITILAYO
18467722 METHOD, THE COMPUTING DEIVCE, AND THE NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM FOR PROVIDING COGNITIVE TRAINING GEBREMICHAEL, BRUK A

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
17978226 METHODS AND DEVICES OF PROCESSING LOW-DOSE COMPUTED TOMOGRAPHY IMAGES YANG, WEI WEN 14d
18326004 METHOD AND APPARATUS FOR PREDICTING PERSISTENT POSTCONCUSSIVE NEUROPSYCHIATRIC SYMPTOMS USING THALAMOCORTICAL COHERENCE NEWTON, CHAD A 75d
18746300 Pharmaceutical Composition and Method for Treating Neurodegenerative Disorders Utilising the Pharmaceutical Composition MOLOYE, TITILAYO
18641154 COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING PRECOCIOUS PUBERTY SCHACHERMEYER, SAMANTHA LYNN
18398320 EYE IMAGE CAPTURING AND PROCESSING DEVICE SAFAIPOUR, BOBBAK
18467722 METHOD, THE COMPUTING DEIVCE, AND THE NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM FOR PROVIDING COGNITIVE TRAINING GEBREMICHAEL, BRUK A
17935917 PCR DETECTION DEVICE AND SYSTEM HERBERT, MADISON TAYLOR

Top Art Units

Art UnitApps
1615 1
2665 1
1691 1
3715 1
3681 1
2662 1
1758 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18746300 Pharmaceutical Composition and Method for Treating Neurodegenerative Disorders Utilising the Pharmaceutical Composition MOLOYE, TITILAYO 1615 §102§103 Non-Final OA Pending Jun 18, 2024
18641154 COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING PRECOCIOUS PUBERTY SCHACHERMEYER, SAMANTHA LYNN §103 Non-Final OA Pending Apr 19, 2024
18398320 EYE IMAGE CAPTURING AND PROCESSING DEVICE SAFAIPOUR, BOBBAK 2665 §103 Final Rejection Pending Dec 28, 2023
18526010 METHOD FOR ALLEVIATING UTERINE LEIOMYOMA USING NICOTINAMIDE SHIAO, REI TSANG 1691 §103 Non-Final OA 6d Pending Dec 01, 2023
18467722 METHOD, THE COMPUTING DEIVCE, AND THE NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM FOR PROVIDING COGNITIVE TRAINING GEBREMICHAEL, BRUK A 3715 §101§103§112 Final Rejection Pending Sep 14, 2023
18326004 METHOD AND APPARATUS FOR PREDICTING PERSISTENT POSTCONCUSSIVE NEUROPSYCHIATRIC SYMPTOMS USING THALAMOCORTICAL COHERENCE NEWTON, CHAD A 3681 §101 Final Rejection 75d Pending May 31, 2023
17978226 METHODS AND DEVICES OF PROCESSING LOW-DOSE COMPUTED TOMOGRAPHY IMAGES YANG, WEI WEN 2662 §103 Final Rejection 14d Pending Nov 01, 2022
17935917 PCR DETECTION DEVICE AND SYSTEM HERBERT, MADISON TAYLOR 1758 §103 Non-Final OA Pending Sep 27, 2022

Managing Taipei Medical University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month